Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irritable Bowel Syndrome With Diarrhea (IBS-D)”

90 trials

Showing 20 of 90 results

Not applicableStudy completedNCT06543498
What this trial is testing

The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
Dr Anthony Hobson 32
Not applicableStudy completedNCT05754177
What this trial is testing

Safety and Efficacy of a Probiotic Supplement in IBS-D

Who this might be right for
Irritable Bowel Syndrome With DiarrheaIrritable Bowel Syndrome
The Archer-Daniels-Midland Company 46
Large-scale testing (Phase 3)Ended earlyNCT02239926
What this trial is testing

Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
Mayo Clinic 5
Not applicableStudy completedNCT01624610
What this trial is testing

Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
University of Michigan 100
Not applicableLooking for participantsNCT06317441
What this trial is testing

The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gastrointestinal Symptoms

Who this might be right for
Small Intestinal Bacterial OvergrowthSIBO
Nimble Science Ltd. 105
Testing effectiveness (Phase 2)Looking for participantsNCT06727422
What this trial is testing

Efficacy of Rifaximin With NAC in IBS-D

Who this might be right for
IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)
Mark Pimentel, MD 225
Large-scale testing (Phase 3)WithdrawnNCT02320318
What this trial is testing

12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
Menarini Group
Testing effectiveness (Phase 2)Looking for participantsNCT07545759
What this trial is testing

Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

Who this might be right for
Irritable Bowel SyndromeDiarrhea
Eli Lilly and Company 531
Testing effectiveness (Phase 2)Study completedNCT02757105
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
RedHill Biopharma Limited 127
Testing effectiveness (Phase 2)Study completedNCT00230581
What this trial is testing

8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS

Who this might be right for
Irritable Bowel Syndrome
Dynogen Pharmaceuticals 88
Not applicableLooking for participantsNCT07656623
What this trial is testing

Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, or Stress

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
Institute of Gastroenterology and Hepatology, Vietnam 60
Very early researchNot Yet RecruitingNCT07238790
What this trial is testing

Use of A Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea

Who this might be right for
IBS (Irritable Bowel Syndrome)Diarrhea
Stanford University 13
Not applicableUnknownNCT04138186
What this trial is testing

G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea

Who this might be right for
Irritable Bowel Syndrome With Diarrhea (IBS-D)
Glock Health, Science and Research GmbH 30
Not applicableStudy completedNCT04806386
What this trial is testing

The Role of Fiber in the Prevention and Treatment of Fecal Incontinence

Who this might be right for
Fecal IncontinenceIrritable Bowel Syndrome With Diarrhea
Massachusetts General Hospital 31
Not applicableStudy completedNCT05523427
What this trial is testing

Probiotics as Adjuvant Therapy in the Management of Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea
University of Mosul 100
Large-scale testing (Phase 3)Study completedNCT01100684
What this trial is testing

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
Tioga Pharmaceuticals 611
Testing effectiveness (Phase 2)Study completedNCT00394173
What this trial is testing

Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome With Diarrhea (IBS-D)
Novartis 180
Post-approval studies (Phase 4)Not Yet RecruitingNCT07574320
What this trial is testing

Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndrome

Who this might be right for
IBS-D (Diarrhea-predominant)
Md. Aminul Islam 76
Large-scale testing (Phase 3)UnknownNCT02504060
What this trial is testing

Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment

Who this might be right for
Irritable Bowel Syndrome
Third Military Medical University 720
Not applicableLooking for participantsNCT06681012
What this trial is testing

Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl 330
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation